Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
165.6 INR | -1.93% |
|
-3.75% | -3.09% |
Jun. 28 | Dishman Carbogen Amcis Receives FDA Clearance for Swiss Manufacturing Facilities | MT |
May. 31 | Transcript : Dishman Carbogen Amcis Limited, Q4 2024 Earnings Call, May 31, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
DISHMAN CARBOGEN AMCIS LIMITED | Other Pharmaceuticals | -1.93% | -3.75% | -3.09% | +18.85% | -21.22% | 317M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- DCAL Stock
- Charts Dishman Carbogen Amcis Limited
- Relative Strength Chart